140 related articles for article (PubMed ID: 9491136)
1. Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in patients with advanced colorectal cancer: Taiwan experience.
Wang WS; Chen PM; Chiou TJ; Liu JH; Lin JK; Lin TC; Chen WS; Jiang JK; Yen CC; Fan FS; Hsieh RK
Jpn J Clin Oncol; 1998 Jan; 28(1):16-9. PubMed ID: 9491136
[TBL] [Abstract][Full Text] [Related]
2. A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.
Yeh KH; Cheng AL; Lin MT; Hong RL; Hsu CH; Lin JF; Chang KJ; Lee PH; Chen YC
Anticancer Res; 1997; 17(5B):3867-71. PubMed ID: 9427794
[TBL] [Abstract][Full Text] [Related]
3. Five-day continuous infusion of 5-fluorouracil and pulsed folinic acid in patients with metastatic colorectal carcinoma: an effective second-line regimen.
Streit M; Jaehde U; Stremetzne S; Ridwelski K; Kerz H; Strohbach F; Hohenberger P; Zwiebel FM; Hebart H; Böthig R; Kairies M; Zillig D; Schuchmann S; Warnecke S; Thiel E; Kreuser ED
Ann Oncol; 1997 Nov; 8(11):163-5. PubMed ID: 9426339
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of irinotecan, 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer.
Ji SH; Park YS; Lee J; Lim DH; Park BB; Park KW; Kang JH; Lee SH; Park JO; Kim K; Kim WS; Jung CW; Im YH; Kang WK; Park K
Jpn J Clin Oncol; 2005 Apr; 35(4):214-7. PubMed ID: 15845571
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of trimetrexate, fluorouracil, and leucovorin for advanced colorectal cancer.
Blanke CD; Kasimis B; Schein P; Capizzi R; Kurman M
J Clin Oncol; 1997 Mar; 15(3):915-20. PubMed ID: 9060528
[TBL] [Abstract][Full Text] [Related]
6. [A retrospective study of irinotecan plus fluorouracil and l-leucovorin chemotherapy for advanced and metastatic colorectal cancer].
Kamoshita N; Makita F; Kobayashi M; Matsuzaki Y; Kabeya K
Gan To Kagaku Ryoho; 2007 Mar; 34(3):397-401. PubMed ID: 17353631
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of weekly low-dose CPT-11 combined with 5-FU/l-LV therapy for advanced and recurrent colorectal cancer--preliminary study].
Tsubono M; Kaneko I; Kii E; Murata T; Deguchi Y; Sonoda K; Yasuda K
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1273-8. PubMed ID: 16969024
[TBL] [Abstract][Full Text] [Related]
8. Double modulation with methotrexate and L-leucovorin of weekly 24- hour fluorouracil infusion in fluorouracil-refractory colorectal cancer.
Colleoni M; Nelli P; Vicario G; Pancheri F; Sgarbossa G; Manente P
Anticancer Res; 1996; 16(5B):3101-4. PubMed ID: 8920775
[TBL] [Abstract][Full Text] [Related]
9. Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer.
Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Tixi LM; Bolli EA; Rosso R; Mammoliti S; Rollandi GA; Bertoglio S
Clin Cancer Res; 1995 Sep; 1(9):955-60. PubMed ID: 9816066
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of irinotecan alternated with a weekly schedule of oxaliplatin, high-dose leucovorin and 48-hour infusion 5-fluorouracil in patients with advanced colorectal cancer.
Rosati G; Tucci A; Rinaldi A; Colarusso D; Pizza C; Reggiardo G; Manzione L
Oncology; 2004; 66(5):371-8. PubMed ID: 15331924
[TBL] [Abstract][Full Text] [Related]
11. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma.
Lin CC; Hsu CH; Huang CY; Cheng AL; Vogelzang NJ; Pu YS
J Urol; 2007 Jan; 177(1):84-9; discussion 89. PubMed ID: 17162009
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of oral tegafur-uracil and folinic acid as first-line therapy for metastatic colorectal cancer: Taiwan experience.
Lin JK; Wang WS; Hsieh RK; Hsu TC; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
Jpn J Clin Oncol; 2000 Nov; 30(11):510-4. PubMed ID: 11155922
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX-4) as salvage chemotherapy in patients with pretreated colorectal cancer.
Shitara K; Munakata M; Muto O; Kasai M; Okada R; Mitobe S; Sakata Y
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1079-84. PubMed ID: 17637544
[TBL] [Abstract][Full Text] [Related]
15. Treatment of advanced-stage colorectal adenocarcinoma with fluorouracil and high-dose leucovorin calcium: a pilot study.
Hines JD; Zakem MH; Adelstein DJ; Rustum YM
J Clin Oncol; 1988 Jan; 6(1):142-6. PubMed ID: 3257256
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H
Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
[TBL] [Abstract][Full Text] [Related]
18. Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy.
Doroshow JH; Multhauf P; Leong L; Margolin K; Litchfield T; Akman S; Carr B; Bertrand M; Goldberg D; Blayney D
J Clin Oncol; 1990 Mar; 8(3):491-501. PubMed ID: 2407810
[TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of chemotherapy with irinotecan (CPT-11), l-leucovorin (l-LV), 5-fluorouracil (5-FU), and UFT for metastatic or recurrent colorectal cancer].
Ito T; Hata Y; Matsuoka S; Nakajima N; Yokoyama R; Honda S; Sano F; Akasaka Y; Ohmori K
Gan To Kagaku Ryoho; 2005 Sep; 32(9):1289-93. PubMed ID: 16184926
[TBL] [Abstract][Full Text] [Related]
20. Factors predictive of response and survival in patients with metastatic colorectal cancer in Taiwan.
Wang WS; Fan FS; Hsieh RK; Chiou TJ; Lin JK; Lin TC; Yen CC; Liu JH; Hsu H; Chen PM
Jpn J Clin Oncol; 1997 Jun; 27(3):174-9. PubMed ID: 9255273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
